Gamma‐glutamylcysteine ethyl ester protects cerebral endothelial cells during injury and decreases blood–brain barrier permeability after experimental brain trauma
Authors:
Open Access
- 29 April 2011
- journal article
- research article
- Published by Wiley in Journal of Neurochemistry
- Vol. 118 (2) , 248-255
Abstract
J. Neurochem.(2011)118, 248–255. Oxidative stress is a pathway of injury that is common to almost all neurological conditions. Hence, methods to scavenge radicals have been extensively tested for neuroprotection. However, saving neurons alone may not be sufficient in treating CNS disease. In this study, we tested the cytoprotective actions of the glutathione precursor gamma‐glutamylcysteine ethyl ester (GCEE) in brain endothelium. First, oxidative stress was induced in a human brain microvascular endothelial cell line by exposure to H2O2. Addition of GCEE significantly reduced formation of reactive oxygen species, restored glutathione levels which were reduced in the presence of H2O2, and decreased cell death during H2O2‐mediated injury. Next, we asked whether GCEE can also protect brain endothelial cells against oxygen–glucose deprivation (OGD). As expected, OGD disrupted mitochondrial membrane potentials. GCEE was able to ameliorate these mitochondrial effects. Concomitantly, GCEE significantly decreased endothelial cell death after OGD. Lastly, ourin vivoexperiments using a mouse model of brain trauma show that post‐trauma (10 min after controlled cortical impact) administration of GCEE by intraperitoneal injection results in a decrease in acute blood–brain barrier permeability. These data suggest that the beneficial effects of GCEE on brain endothelial cells and microvessels may contribute to its potential efficacy as a neuroprotective agent in traumatic brain injury.Keywords
This publication has 40 references indexed in Scilit:
- Mitochondrial protection after traumatic brain injury by scavenging lipid peroxyl radicalsJournal of Neurochemistry, 2010
- Antioxidant Therapies for Traumatic Brain InjuryNeurotherapeutics, 2010
- Melatonin Potentiates the Neuroprotective Properties of Resveratrol Against Beta-Amyloid-Induced Neurodegeneration by Modulating AMP-Activated Protein Kinase PathwaysJournal of Clinical Neurology, 2010
- Nitrative and Oxidative Stress in Toxicology and DiseaseToxicological Sciences, 2009
- Drug targets for traumatic brain injury from poly(ADP‐ribose)polymerase pathway modulationBritish Journal of Pharmacology, 2009
- Reduced Tissue Damage and Improved Recovery of Motor Function after Traumatic Brain Injury in Mice Deficient in Complement Component C4Journal of Cerebral Blood Flow & Metabolism, 2007
- In vitro and in vivo neuroprotection by γ-glutamylcysteine ethyl ester against MPTP: Relevance to the role of glutathione in Parkinson's diseaseNeuroscience Letters, 2006
- Elevation of mitochondrial glutathione by γ‐glutamylcysteine ethyl ester protects mitochondria against peroxynitrite‐induced oxidative stressJournal of Neuroscience Research, 2003
- Elevated glutathione as a therapeutic strategy in Alzheimer's diseaseDrug Development Research, 2002
- Idiopathic Parkinson's disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patientsNeuroscience Letters, 1986